AGEN Stock Chart





Fundamentals AGEN

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Cash Ratio, FY ---
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---
alexrich700 alexrich700 AGEN, D, Short ,
AGEN: Descending Triangle forming on AGEN
47 0 4
AGEN, D Short
Descending Triangle forming on AGEN

Will be looking to enter under 3.60 NASDAQ:AGEN

ivincorp ivincorp AGEN, D, Long ,
13 0 1
AGEN, D Long
AGEN long


AntonioNaVi AntonioNaVi PRO AGEN, D, Long ,
AGEN: >6.31 potencial patrón de continuación
38 0 2
AGEN, D Long
>6.31 potencial patrón de continuación

el precio debe mantenerse por encima de su EMA21 para continuar con potencial movimiento a la alza

NaughtyPines NaughtyPines AGEN, W, Long ,
21 0 1
AGEN, W Long

This little fella popped up on my radar earlier today as having high implied volatility, so I pretty much blindly put on the covered call then and there, buying 100 shares a 6.24 and selling the Sept 16th 7 put for a 5.77 debit (which will be my cost basis in the shares). The max profit is $123 with a ROC of about 21.3% (assuming a call away at 7).

wangweiandwang33 wangweiandwang33 AGEN, D, Long ,
AGEN: How to make 80% return in three month with Agen
16 0 0
AGEN, D Long
How to make 80% return in three month with Agen

Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody ...

MoneyFlowTrader MoneyFlowTrader AGEN, 240, Long ,
AGEN: bullish inverse Head & Shoulders
45 0 1
AGEN, 240 Long
bullish inverse Head & Shoulders

w/ a possible bull flag on 4hr time, watch for b/o of blue triangle

MoneyFlowTrader MoneyFlowTrader AGEN, D,
AGEN: daily chart looks promising but needs volume
25 0 1
daily chart looks promising but needs volume

watch the 50% fib level if no vol, could be a false b/o. which would lead to a sell off

JPMorgains JPMorgains AGEN, D,
21 0 1
AGEN Wedge

Another big wedge. Some insiders buy this month. Worth watching.

penniestothousands penniestothousands PRO AGEN, D, Long ,
AGEN: pennies to thousands biotech candidate
5 0 0
AGEN, D Long
pennies to thousands biotech candidate

above cloud good base get our book on patterns we like on amazon immunotherapy play lots of net cash relative strength good in development with merk beaten down now with good technicals

MarketMonk MarketMonk AGEN, 15, Short ,
AGEN: AGEN short term shorting on downward triangle
9 0 0
AGEN, 15 Short
AGEN short term shorting on downward triangle

Decent chance to short to 3.90-4.00 range, depending on morning price action. Price consolidation occurred throughout the intraday trend and has now broken past the downward triangle pattern where the price has fallen below the 20 period BB. Stop loss should be at 4.15-4.20 range if price reverses past the EVWMA lines which act as our trend reversal signal mechanism.

Sanctum_Investment_Group Sanctum_Investment_Group AGEN, 60, Short ,
AGEN: Overvalued Earnings
12 0 1
AGEN, 60 Short
Overvalued Earnings

Despite reporting 4Q losses, Agenus Inc. (or the company) showed an increase in share price. This shocked many analysts and some concluded that this was due to the earnings report exceeding revenue. But now the "Earnings Hype" is over for revenue does not do anything to the EPS if the company cannot clear its margins and produce profit. This will lead to a bearish ...

YoungMula YoungMula AGEN, D, Short ,
AGEN: Short Idea 5 Month Downtrend Channel 1:7 R/R
58 0 3
AGEN, D Short
Short Idea 5 Month Downtrend Channel 1:7 R/R

Target $3 Stop $4.65

Y2C Y2C AGEN, W, Short ,
AGEN: Crazy Biotech Stocks
14 0 0
AGEN, W Short
Crazy Biotech Stocks

Took this roller coaster from 4.50 to 9.50.. Crazy to think it is back to my old price from beginning of this year.. Target 3.50 next downside target from here

jmena07 jmena07 AGEN, D,
AGEN: AGEN Beginner chart
50 1 1
AGEN Beginner chart

After the 50 MA cross, projecting to continue its pattern while all the indicators are looking positive

Ideas Scripts Chart
United States
United Kingdom
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out